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EDITORIAL
A mutually beneficial collaboration 
between the European Academy of Allergy 
and Clinical Immunology Junior Members 
and Clinical and Translational Allergy
Peter Valentin Tomazic1†, Anke Graessel2, Diana Silva3,4, Ibon Eguiluz‑Gracia5, George V. Guibas6, Clive Grattan7, 
Jean Bousquet8,9,10,11 and Olympia Tsilochristou12*† 
Abstract 
The European Academy of Allergy and Clinical Immunology (EAACI) Junior Members (JM) comprise the largest EAACI 
section with around 4000 clinicians and scientists under 35 years of age working in the field of allergy and clinical 
immunology. The Junior Member collaboration with Clinical and Translational Allergy Journal is a mutually beneficial 
relationship providing Junior Members of EAACI with excellent opportunities to publish their work in the Journal, 
enhance their visibility in their respective field, and get involved with Journal‑related activities and processes. In the 
future, this collaboration will grow, not only by the consolidation of these activities, but also by the implementation of 
new initiatives, such as a platform for discussing and/or publishing Junior Members’ dissertations in the Journal. From 
the CTA perspective, the collaboration presents an opportunity to promote a new generation of allergists with experi‑
ence of conducting and presenting research, with improved skills in critical review.
Keywords: EAACI, Junior Members, Clinical and Translational Allergy, Collaboration, Allergy
© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The European Academy of Allergy and Clinical Immu-
nology (EAACI) Junior Members (JM) comprise the 
largest EAACI section with around 4000 clinicians and 
scientists under 35  years of age working in the field of 
allergy and clinical immunology. EAACI JM benefit from 
free EAACI membership, reduced registration fees for 
the EAACI events (Annual Congress, Focused Meetings 
and Allergy Schools), free online access to the EAACI 
Journals and educational resources and the possibility of 
applying for the EAACI Mentorship Programme, Clinical 
and Research Fellowships, Scholarships and travel grants. 
The JM working group (WG), founded in 2001 [1], is 
the representative body of the JM within EAACI as an 
organisation. The JM WG has been receiving support and 
encouragement from the EAACI leadership and has thus 
been able to coordinate a number of initiatives such as: 
(a) Involvement in the organization and planning of ses-
sions for the EAACI Congresses, Focused Meetings and 
Allergy Schools. In particular, the JM WG operates its 
own programme at all EAACI Congresses, which apart 
from scientific meetings involves several social activi-
ties that help juniors get to know each other better in a 
more relaxed environment (b) Establishment of JM social 
media accounts (on Facebook, Twitter and LinkedIn) 
with the aim of increasing the flow of information, visibil-
ity, communication and networking among JM. (c) Devel-
opment and update of the JM dedicated webpages on 
eaaci.org. (d) The Mentorship Programme supporting the 
communication between seniors and juniors. (e) Coor-
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publications from English into other main European lan-
guages e.g. “A new framework for the interpretation of 
IgE sensitization tests” [2], the International Consensus 
documents on Drug Allergy [3] and Pediatric Asthma [4] 
as well as resources and webpages on EAACI’s campaign 
(e.g. bewareofallergy.com); and (f ) Collaboration with the 
Editorial Boards of the three EAACI Journals, namely the 
European Journal of Allergy and Clinical Immunology 
(Allergy), Pediatric Allergy and Immunology (PAI), Clini-
cal and Translational Allergy (CTA), with the aim of pro-
moting the articles published by these Journals.
The primary aim of Clinical and Translational Allergy 
is to publish high quality translational research in allergy 
for clinicians and their patients using an open access 
platform to allow unrestricted availability and dissemi-
nation through social media. A secondary objective is to 
promote high standards of critical assessment of manu-
scripts through the review process by EAACI Junior 
Members.
The JM‑CTA collaboration
Clinical and Translational Allergy, is the youngest jour-
nal in the portfolio of EAACI and provides a platform 
for the dissemination of allergy research and reviews, 
EAACI task force reports, position papers and guidelines 
amongst an international scientific audience. It accepts 
clinical and translational research articles in the field 
of allergy and immunology and all its articles are open-
access and exclusively web-based, thus ensuring a wide 
dissemination of its content.
The JM-CTA collaboration aims at promoting the 
Journal’s scientific output and increasing its visibility 
amongst the EAACI Junior and Senior members as well 
as the general allergy-interested community. In addition, 
JM can extend their influence and input within the Jour-
nal. The juniors that comprise the JM-CTA collaboration 
team are members of the JM WG and are responsible for:
  • Monthly selection of the CTA ‘JM Must Read arti-
cles‘; these articles are specifically flagged on the 
CTA homepage, because they are most relevant to 
fellows in training based on their educational con-
tent. Due to the open access policy of the Journal, all 
juniors can easily download these articles.
  • Active promotion of CTA in the most popular social 
media networks; all recent and past, highly accessed 
articles are posted on EAACI’s Facebook and Twitter 
account with the hashtag #CTA_Journal.
  • Organization and development of webcasted inter-
views; leading authors of recently published CTA 
articles are invited to be interviewed by a JM. The 
purpose of this initiative is to promote the article, 
give JMs the opportunity to meet senior authors per-
sonally and discuss details of their work with them. 
The first interview [5] is already available on the 
EAACI YouTube channel and social media platforms 
as well as on CTA’s homepage.
The CTA Editorial Board has embraced all these initia-
tives and has enhanced them further. Acknowledging the 
importance of education for the junior allergy physicians 
and researchers, the CTA Editorial Board supported the 
following actions:
  • Highlighted the CTA ‘JM Must Read articles’ with 
the EAACI JM logo on CTA’s homepage.
  • Implemented a Twitter live feed in relation to all 
tweets carrying the hashtag #CTA_Journal on the 
Journal’s website ensuring quick information access 
even to web-users not signed up for Twitter.
  • A limited number of full waivers of the Article Pro-
cessing charge (APC) will be available to EAACI JM’s 
to publish their original research in addition to Acad-
emy position papers and guidelines.
  • Invited qualified EAACI JM to act as reviewers for 
the Journal. This not only underlines their recogni-
tion in the field but also enhances their critical view 
on research.
  • Launched two quizzes that were created by the JM of 
the JM-CTA collaboration team in relation to articles 
published in CTA [6, 7]. Upon successful completion, 
the Journal offered waived publication fees for two 
articles submitted by the two JM quiz winners.
  • Released an open call to submit hot topic reviews 
with Juniors as first authors. Four of these articles 
have been published in CTA within the last year. 
Saluja et al. [8] published about the role of interleu-
kin-33 in allergy and inflammation. Ozyigit et al. [9] 
described the role of innate lymphoid cells in asthma. 
Also, reviews with a more clinical and translational 
research orientation were published through this ini-
tiative; Song and Chang [10] published a review deal-
ing with cough hypersensitivity as a neuro-immune 
interaction, while Schrijvers et  al. [11] focused on 
the pathogenesis and diagnosis of delayed-type drug 
hypersensitivity reactions.
Conclusion
The Junior Member collaboration with Clinical and 
Translational Allergy Journal is a mutually beneficial 
relationship providing Junior Members of EAACI with 
excellent opportunities to publish their work in the 
Journal, enhance their visibility in their respective field, 
and get involved with Journal-related activities and pro-
cesses. In the future, this collaboration will grow, not 
only by the consolidation of these activities, but also by 
Page 3 of 3Tomazic et al. Clin Transl Allergy  (2016) 6:43 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
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and we will help you at every step:
the implementation of new initiatives, such as a platform 
for discussing and/or publishing Junior Members’ dis-
sertations in the Journal. From the CTA perspective, the 
collaboration presents an opportunity to promote a new 
generation of allergists with experience of conducting 
and presenting research, with improved skills in critical 
review.
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